Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)
Clinical trial NCT07726563 · RECRUITING
Trial details
- NCT number
- NCT07726563
- Sponsor
- National Taiwan University Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-19
- Primary completion
- 2029-01-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.